Attached files
| file | filename |
|---|---|
| 10-K - Tongli Pharmaceuticals (USA), Inc. | v189393_10-k.htm |
| EX-31.2 - Tongli Pharmaceuticals (USA), Inc. | v189393_ex31-2.htm |
| EX-32.2 - Tongli Pharmaceuticals (USA), Inc. | v189393_ex32-2.htm |
| EX-32.1 - Tongli Pharmaceuticals (USA), Inc. | v189393_ex32-1.htm |
| EX-31.1 - Tongli Pharmaceuticals (USA), Inc. | v189393_ex31-1.htm |
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby
consent to the incorporation by reference in the Registration Statements of
Tongli Pharmaceuticals (USA), Inc. (the “Company”) on Form S-8 (No. 333-163633),
of our report, dated June 28, 2010, relating to the consolidated financial
statements of the Company which appear in this Form 10-K.
/s/
Paritz & Company, P.A.
Hackensack,
New Jersey
June 29,
2010